Shandong Weigao Medical Polymer EBIT 2012-2024 | SHWGF

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Shandong Weigao Medical Polymer ebit from 2012 to 2024. Ebit can be defined as earnings before interest and taxes.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Shandong Weigao Medical Polymer ebit from 2012 to 2024. Ebit can be defined as earnings before interest and taxes.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$223.7B
Boston Scientific (BSX)	$157.9B
Stryker (SYK)	$152.8B
EssilorLuxottica (ESLOY)	$137.4B
Medtronic (MDT)	$117.5B
Lonza Group Ag (LZAGY)	$49.5B
Haleon (HLN)	$43.3B
ResMed (RMD)	$40.7B
Agilent Technologies (A)	$33.5B
GE HealthCare Technologies (GEHC)	$32.8B
Koninklijke Philips (PHG)	$25.8B
Terumo (TRUMY)	$25.1B
Insulet (PODD)	$21B
Zimmer Biomet Holdings (ZBH)	$18.5B
Baxter (BAX)	$14.4B
Smith & Nephew SNATS (SNN)	$13.5B
Sunny Optical Technology (SNPTF)	$10.4B
Demant (WILYY)	$8.6B
Bio-Rad Laboratories (BIO)	$6.8B
Lantheus Holdings (LNTH)	$5B
Perrigo (PRGO)	$3.8B
Prestige Consumer Healthcare (PBH)	$3.7B
Haemonetics (HAE)	$3.6B
Envista Holdings (NVST)	$3.4B
ICU Medical (ICUI)	$3.1B
LeMaitre Vascular (LMAT)	$1.9B
AtriCure (ATRC)	$1.7B
QuidelOrtho (QDEL)	$1.6B
Acuren (TIC)	$1.4B
Green Thumb Industries (GTBIF)	$1.3B